Nov 28 (Reuters) - Medincell SA MEDCL.PA :
* MEDINCELL RECEIVES $19 MILLION GRANT FOR ITS MDC-WWM
PROGRAM
* IT AIMS TO FUND PRECLINICAL ACTIVITIES AND A PHASE 1
CLINICAL
TRIAL FOR THE INJECTABLE SIX-MONTH BIORESORBABLE CONTRACEPTIVE
(MDC-WWM)
* THE GRANT IS STRUCTURED IN ADVANCED INSTALLMENTS TO COVER
THE
COSTS THAT WILL BE INCURRED BY THE PROJECT
* DEPENDING ON OPTIONS CHOSEN AND ON ADVANCEMENT OF PROGRAM,
UP TO
$11.75 MILLION COULD BE RAISED OVER NEXT 12 MONTHS INCLUDING A
FIRST TRANCHE OF $4.75 MILLION TO BE PAID IMMEDIATELY.
* ADDITIONAL $7.25 MILLION MAY BE COLLECTED LATER
Source text for Eikon: ID:nBwbwrHrDa
Further company coverage: MEDCL.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))